List of insiders holdings for IMMUNE DESIGN CORP.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Topspin Fund L.P. LG Management LLC GUTHART LEO 10% Owner | 2018-02-07 15:33:37 | 5,664,739 0 | 5,664,739 | Form 13G |
| GUTHART LEO 10% Owner | 2018-01-10 15:00:30 | 0 5,664,739 | 5,664,739 | Form 4/A |
| Alta Partners VIII L.P. Alta Partners Management VIII LLC NOHRA GUY P JANNEY DANIEL CHAMPSI FARAH 10% Owner | 2014-08-08 11:34:46 | 2,482,775 0 | 2,482,775 | Form 13D |
| Versant Venture Capital III L.P. Versant Side Fund III L.P. 10% Owner | 2019-02-28 16:50:17 | 2,215,549 0 | 2,215,549 | Form 13D |
| ProQuest Investments IV L.P. ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner | 2018-02-14 17:00:00 | 1,236,394 0 | 1,236,394 | Form 13G |
| Kenney Richard T Chief Medical Officer | 2016-01-06 19:36:01 | 37,522 0 | 37,522 | Form 4 |
| Rickey James Paul VP, Finance and Administration | 2015-01-09 16:16:33 | 25,000 0 | 25,000 | Form 4 |
| ATWOOD BRIAN G Director | 2016-01-06 19:03:04 | 9300 0 | 9300 | Form 4 |
| BERGER FRANKLIN M Director | 2019-04-04 17:24:48 | 0 0 | 0 | Form 4 |
| BALTIMORE DAVID Director | 2019-04-04 17:17:58 | 0 0 | 0 | Form 4 |
| Yurasov Sergey Sr. VP, Clinic. Devel. & CMO | 2019-04-04 17:16:49 | 0 0 | 0 | Form 4 |
| Brady Stephen R EVP, Strategy & Finance | 2019-04-04 17:15:34 | 0 0 | 0 | Form 4 |
| Gombotz Wayne Chief Development Officer | 2019-04-04 17:14:50 | 0 0 | 0 | Form 4 |
| Paya Carlos V President and CEO | 2019-04-04 17:14:00 | 0 0 | 0 | Form 4 |
| ter Meulen Jan Henrik Chief Scientific Officer | 2019-04-04 17:13:07 | 0 0 | 0 | Form 4 |
| Kelley Susan L. Director | 2019-04-04 17:12:05 | 0 0 | 0 | Form 4 |
| PENHOET EDWARD Director | 2019-04-04 17:11:11 | 0 0 | 0 | Form 4 |
| RINGO WILLIAM R Director | 2019-04-04 17:10:00 | 0 0 | 0 | Form 4 |
| COLEMAN LEWIS W Director | 2019-04-04 17:06:06 | 0 0 | 0 | Form 4 |
| COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC GOEDDEL DAVID V Kutzkey Tim Svennilson Peter 10% Owner | 2019-04-02 20:57:28 | 0 0 | 0 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 2019-02-25 17:22:31 | 0 0 | 0 | Form 13G |